Table 4 Pregnancy-related serious adverse events (SAEs)
|  | Supplement (n = 70) | Supplement + probiotics (n = 70) | No supplement (n = 68) |  | |||
|---|---|---|---|---|---|---|---|
Pregnancy, puerperium and perinatal conditions | # Events | # Mothers (%) | # Events | # Mothers (%) | # Events | # Mothers (%) | p- value* |
Fetal growth restriction | 0 | 0 (0.0%) | 0 | 0 (0.0%) | 1 | 1 (1.5%) | – |
Gestational hypertension | 1 | 1 (1.4%) | 1 | 1 (1.4%) | 0 | 0 (0.0%) | 1.000 |
Pre-eclampsia | 1 | 1 (1.4%) | 1 | 1 (1.4%) | 1 | 1 (1.5%) | 1.000 |
Premature labor | 3 | 3 (4.3%) | 1 | 1 (1.4%) | 1 | 1 (1.5%) | 0.620 |
Genito-urinary tract infections | 15 | 14 (20.0%) | 9 | 7 (10.0%) | 3 | 3 (4.4%) | 0.154 |
Tolerance: nausea, vomiting and diarrhea | 6 | 4 (5.7%) | 11 | 7 (10.0%) | 1 | 1 (1.5%) | 0.532 |